Thank you for attending the 2018 Annual Conference!  |  We will be adding the recap videos in the next few weeks, check back!

2018 Annual Conference   |   January 31 - February 2, 2018   |   Salt Lake City, Utah, USA

Sponsorship Opportunities are now open.

Conference Chairs
Nabeel Bardeesy, PhD
Nabeel Bardeesy, PhD
Katie Kelley, MD
Katie Kelley, MD

2018 Cholangiocarcinoma Foundation Annual Conference

The Cholangiocarcinoma Foundation's annual program seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma by providing a forum to:


Increase knowledge central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma.

A New Perspective

Present a diversity of perspectives focused on clinical, basic, and translational research.


Stimulate multi-disciplinary, cross-institutional collaborations.


Foster dialogue
and inspire innovation.

Further, because patients living with cholangiocarcinoma have a direct stake in their own medical care and are in a unique position to provide input, CCF has expanded its Annual Conference to include programming that addresses questions and concerns that are important to patients and their families. Patients and caregivers—having experienced the disease firsthand—will be invited to learn about cholangiocarcinoma, share their personal experiences, and contribute to future efforts to further cholangiocarcinoma research.

Who Should Attend?

Who Should Attend?

  • Researchers
  • Physicians
  • Oncologists
  • Radiologists
  • Surgeons
  • Gastroenterologists
  • Hepatologists
  • Nurses specializing in oncology, intensive care, and palliative care
  • Pharmaceutical Companies
  • Government Regulators
  • Policymakers
  • Patients, Caregivers and others invested in the field of cholangiocarcinoma

Incredible Numbers from our 2017 Conference


from 26 states and 16 countries representing healthcare, industry, patient advocacy organizations, patients, caregivers, academia and supporters.


including researchers, surgeons, patients, caregivers and industry specialists.

PCORI Awardees

Patient-Centered Outcomes Research Institute scholarship awardees from the United States, Australia and Malaysia.


  • 89 physicians/researchers
  • 76 institutions
  • 128 patients/caregivers


  • 38 poster presenters
  • 230 webcast attendees
  • 67 sessions

with support from

  • 23 organizations: ASLAN Pharmaceuticals, Agios, ArQule, Boston Scientific, Bristol-Myers Squibb, Celgene Corporation, CellAct, doTERRA, Halozyme, Ignyta, Incyte, Leap Therapeutics, Lilly Oncology, Merck, NIH, Nucana, PCI Biotech, PCORI, Promotion in Motion, RedHill Biopharma, Shire, Sirtex, and University of Utah.

Don't Wait, Be a Part of our 2018 Conference

Thank you to our supporters...

Boston Scientific
Conquer Cancer Foundation
H3 Biomedicine
Promotion in Motion


Funding for this conference was made possible (in part) by a Eugene Washington Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI) allowing 30 patients from around the world to take part in all facets of the conference including speaking, attending sessions, roundtable discussions, and networking events.

Endorsed by AHPBA